Companies / Gedea Biotech
Gedea Biotech
Sweden
Gedea Biotech develops and commercializes treatments for vaginal infections, including bacterial vaginosis and vaginal fungal infections.
Gedea Biotech, based in Sweden, has 1 investor on file, among them Convergence Partners. Its site was last checked 10 Nov 2026: site answers.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital |
More from Convergence Partners
32 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (69%), Gaming (5%), Consumer (5%).
See Convergence Partners' full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Gedea Biotech and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Convergence Partners adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/gedeabiotech.com/investors
# also
GET /v1/companies/gedeabiotech.com
GET /v1/companies/gedeabiotech.com/news